[Necrosis of the jaws under bisphosphonate therapy].
Bisphosphonates are widely used in the treatment of cancer patients with hypercalcemia and bone metastases or in osteoporosis therapy. Current reports have focused on therapy-resistant osteonecrosis of the jaws as a possible side effect of bisphosphonates. Official German drug committees have recently warned about the possibility of these side effects. So far we have experience with 12 patients showing therapy-resistant osteonecrosis of the mandible under bisphosphonate medication, three of whom received oral bisphosphonates for osteoporosis treatment. Presentation of these three cases provides more information on this clinically important side effect of oral bisphosphonate medication, also in osteoporosis therapy.
Hoefert
S
S
Klinik für Mund-, Kiefer- und Gesichtschirurgie -- Plastische Operationen -- im Knappschaftskrankenhaus Recklinghausen. sebastian.hoefert@ruhr-uni-bochum.de
Eufinger
H
H
D000368:Aged; D002114:Calcinosis / Q000188:drug therapy; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced* / Q000175:diagnosis* / Q000517:prevention & control; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced* / Q000175:diagnosis* / Q000517:prevention & control; D010024:Osteoporosis / Q000188:drug therapy
D004164:Diphosphonates